Diabetic Shoes Update: CMS Publicizes Clarification It Provided to APMA
Summary: The Centers for Medicare & Medicaid Services (CMS) has publicly released a clarification it provided to the American Podiatric Medical Association (APMA) regarding therapeutic diabetic footwear coverage. The update addresses key documentation, billing, and qualification requirements, aiming to reduce claim denials and improve access for patients at risk of diabetic foot ulcers.
Key Highlights:
- CMS clarifies coverage criteria for diabetic shoes and inserts
- Important guidance on required documentation and physician statements
- Helps reduce administrative burden and claim denials
- Strengthens access to preventive therapeutic footwear
Keywords: diabetic shoes CMS, therapeutic footwear, APMA diabetic shoes